Agios Pharmaceuticals AGIO Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Agios Pharmaceuticals’s reported figures.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's invested capital?
- Agios Pharmaceuticals (AGIO) reported invested capital of $1.03B in Q1 2026.
- How has Agios Pharmaceuticals's invested capital changed year-over-year?
- Agios Pharmaceuticals's invested capital decreased by 28.4% year-over-year, from $1.44B to $1.03B.
- What is the long-term trend for Agios Pharmaceuticals's invested capital?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's invested capital has grown at a 24.8% compound annual growth rate (CAGR), from $377.26M to $1.14B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).